13 Sep, 2024 Navigating the Evolving Regulatory Landscape: The Role of Strategic Partnerships in Biopharmaceuticals By Bruna Rocha Victoria Cristofaro Camila Dulcine Decoding the regulatory conundrum Biopharmaceutical companies are navigating an increasingly complex global regulatory landscape that...
11 Sep, 2024 Navigating EU and national regulatory scrutiny in so called “killer acquisitions” By Alexandra Kamerling Darach Connolly Zoltan Marosi Daniel Colgan Amanda Wait +2 more... Show less The implications of the recent Illumina/Grail Judgment Executive Summary In a landmark EU judgment, on 3 September 2024, the Court of...
09 Sep, 2024 Life Sciences News in Italy: August 2024 By DLA Piper Life Sciences Regulatory AIFA updates Guidelines for the classification and conduct of observational studies on medicines On 20 August 2024, the...
04 Sep, 2024 Poland - Life Sciences Monthly Brief, August 2024 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our July monthly briefing, which covers key updates and insights in the following areas: Medicinal products;Medical...
04 Sep, 2024 Anticorruption and anti-money laundering top the UAE’s enforcement agenda: Key takeaways for the Life Sciences Sector By Adam Vause Celia Johnson-Morgan Katie Edwards Governments around the world continue to place corporate crime at the top of their enforcement agendas, and the United Arab Emirates...